BPC-157 Analytical Profile

For laboratory research use only. Not for human or veterinary use. This article covers the chemistry and analytical testing of BPC-157 as a research material.

BPC-157 is a synthetic 15-residue peptide. The useful questions about any lot of it are analytical. Is the sequence right? How much of the powder is peptide? What else is in the vial, and could any of it interfere with an assay?

This page is a reference for those questions. It covers the identifiers to check against, the masses a spectrometer should report, and how to read a certificate of analysis without reading more into it than it says.

BPC-157 at a Glance

• Sequence (one-letter): GEPPPGKPADDAGLV
• Sequence (three-letter): Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
• Length: 15 residues, linear
• Termini: free N-terminal amine, free C-terminal carboxylic acid
• Molecular formula: C₆₂H₉₈N₁₆O₂₂
• Average molecular weight: 1419.5 g/mol
• Monoisotopic mass: 1418.70 Da
• CAS number: 137525-51-0
• PubChem CID: 9941957

The formula and masses are for the free peptide [1]. A salt form, such as an acetate or trifluoroacetate salt, weighs more per mole of peptide. That difference matters later in this article.

What the Sequence Tells You

A few features of the sequence are worth knowing before you look at any test result.

No residues prone to oxidation or deamidation. BPC-157 contains no cysteine, methionine, or tryptophan, the residues most susceptible to oxidation. It also has no asparagine or glutamine, which are prone to deamidation. Bachem’s handling guidance notes that peptides containing those residues tend to have a limited shelf life [2]. BPC-157 has none of the five.

It takes up moisture. GenScript’s handling guidance notes that peptides containing Asp, Glu, Lys, Arg, or His absorb moisture from the air and should be stored in a desiccator [3]. BPC-157 has four of those residues (Glu2, Lys7, Asp10, Asp11). Bachem notes that absorbed moisture lowers the peptide content of the solid and may reduce stability. It recommends letting a container reach room temperature in a desiccator before opening it [4].

It’s an acidic peptide. The sequence has three acidic side chains (Glu2, Asp10, Asp11) and one basic side chain (Lys7). Counting the free N- and C-termini, the net charge near neutral pH is about -2. Bachem’s general rule is to dissolve acidic peptides in a basic buffer and basic peptides in an acidic one [2].

Two adjacent aspartic acids. Positions 10 and 11 are both Asp. Aspartic acid is a well-known site for aspartimide formation during solid-phase peptide synthesis. That side reaction can leave a by-product 18 Da lighter than the target. It can also leave isomers with exactly the same mass as the target. Both show up again when you read a mass spec result.

What HPLC Purity Does and Doesn’t Tell You

The headline number on most COAs is HPLC purity. It comes from reversed-phase HPLC with UV detection, typically around 214 to 220 nm, where peptide bonds absorb. The figure is the area of the main peak as a percentage of the total area of all detected peaks.

That makes it a useful number with real limits:

• It only counts what the detector sees. Water, salts, and counterions don’t appear in it.
• It doesn’t confirm identity. A single clean peak tells you the material is homogeneous. It doesn’t tell you the material is BPC-157. Mass spectrometry answers that.
• Impurities that elute with the main peak count as product. Isomers that differ only in the configuration or linkage of one residue can be hard to separate from the main peak.
• It depends on the method. Column, gradient, and wavelength all affect the result. A purity figure without the chromatogram and method behind it is hard to evaluate.

Research-grade synthetic peptides are typically above 95% pure by HPLC [2]. Whatever the figure, the COA should include the chromatogram it was calculated from.

What Mass Spectrometry Should Show

Mass spec answers a different question: does the main component have the right mass? Electrospray ionization is the most common setup for peptides. With it, these are the ions to expect for BPC-157 (monoisotopic values):

• [M+H]⁺: 1419.71
• [M+2H]²⁺: 710.36
• [M+Na]⁺ (sodium adduct): 1441.69

Some reports use average mass instead, especially from lower-resolution instruments. A neutral mass near 1419.5, or about 1420.5 for [M+H]⁺, is also consistent. What matters is that the report says which value it gives, and that the observed number matches within the instrument’s stated accuracy.

Some mass differences point to specific problems:

• About 97 Da low (neutral mass near 1321.65): a missing proline. With four prolines in the sequence, a proline deletion is a plausible synthesis by-product.
• About 57 Da low (near 1361.68): a missing glycine.
• About 18 Da low (near 1400.69): consistent with aspartimide formation at Asp10 or Asp11.

Mass alone can’t prove everything. A peptide with the same 15 residues in a different order has exactly the same mass. So does a version where one aspartic acid has rearranged into its beta isomer. Confirming sequence order takes tandem mass spectrometry (MS/MS), and confirming composition takes amino acid analysis. Most COAs include neither, which is normal. It’s still worth knowing what a single mass reading can and can’t establish.

Purity Is Not Content

This distinction causes the most confusion. A lyophilized peptide is never 100% peptide by weight. The powder also holds counterions left over from purification, usually acetate or trifluoroacetate, plus residual water, which rises if the powder has been exposed to humid air. Bachem puts the peptide content of a typical lyophilized solid at 70 to 90% [2].

So a lot can be 99% pure by HPLC and about 80% peptide by weight at the same time. Both numbers are correct. They measure different things.

The figure that tells you how much peptide is in the vial is net peptide content. It’s usually determined by amino acid analysis or nitrogen analysis. Say you prepare a stock solution at a set molar concentration using the gross powder weight. The real concentration will be roughly 70 to 90% of what you calculated, and that error carries into every dilution after it.

Check two things: whether the mass on the label is gross powder weight or net peptide, and whether the COA reports net peptide content at all. Many don’t.

Counterions: Why TFA Matters for Cell Work

Trifluoroacetic acid (TFA) is standard in reversed-phase peptide purification. Unless a peptide goes through a salt exchange step, it often ends up as a TFA salt. For many analytical uses that makes no difference. In cell-based assays it can.

In a 1999 study in the American Journal of Physiology, Cornish and colleagues found that trifluoroacetate reduced cell numbers in fetal rat osteoblast cultures at concentrations as low as 10 nM, with similar effects in chondrocytes [5]. They also compared TFA and hydrochloride salts of the same peptides. The TFA versions consistently showed less proliferation. The gap was large enough to hide a real proliferative effect, or to suggest an antiproliferative effect that wasn’t there.

If a lot is headed for cell culture, find out the counterion. Acetate and hydrochloride salts are the usual alternatives. A COA that states the salt form answers the question up front.

Endotoxin, If Your Work Involves Immune Cells

Bacterial endotoxin (lipopolysaccharide) can be introduced during manufacturing, and freeze-drying doesn’t remove it. Immune cells respond to it at very low levels through TLR4 signaling. In a macrophage or monocyte assay, endotoxin contamination can produce an inflammatory readout that has nothing to do with the peptide being studied.

Endotoxin is measured with the Limulus amebocyte lysate (LAL) test described in USP General Chapter 85, Bacterial Endotoxins Test. Results are reported in endotoxin units per milligram (EU/mg) [6]. Many research-grade COAs don’t include it. If it matters for your work, ask for it.

A Practical COA Checklist

A certificate of analysis is only as useful as what it lets you verify. For a BPC-157 lot, a complete one should include:

• Product name, sequence, and a lot number that matches the vial
• The test date, the name of the lab that ran the analysis, and whether that lab is independent of the seller
• HPLC purity with the chromatogram attached and the method basics (column, gradient, detection wavelength)
• A mass spec result showing observed and expected values, and which ion or mass type is reported
• Net peptide content, if the label mass is meant to represent peptide rather than powder
• The salt form or counterion
• An endotoxin result, where it’s relevant to the work

These should prompt a closer look:

• The same COA, chromatogram, or test date appearing across different lots
• A purity figure with no chromatogram behind it
• A mass value with no indication of whether it’s average, monoisotopic, or a specific ion
• A testing lab you can’t identify or contact
• A lot number on the COA that doesn’t appear on the vial

None of this requires running the analysis yourself. It requires knowing which number answers which question, and noticing when a document gives you a number without the evidence behind it.

References

1. National Center for Biotechnology Information. PubChem Compound Summary for CID 9941957, BPC-157. pubchem.ncbi.nlm.nih.gov
2. Bachem. Care and Handling of Peptides. Technical note. bachem.com/knowledge-center
3. GenScript. Peptide Storage and Handling Guidelines. genscript.com
4. Bachem. Handling and Storage Guidelines for Peptides. bachem.com/knowledge-center
5. Cornish J, Callon KE, Lin CQ, Xiao CL, Mulvey TB, Cooper GJ, Reid IR. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. American Journal of Physiology. 1999;277(5):E779-E783. doi:10.1152/ajpendo.1999.277.5.E779. PMID: 10567002
6. United States Pharmacopeia. General Chapter 85, Bacterial Endotoxins Test.